| Next-generation characterization of the cancer cell line encyclopedia M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ... Nature 569 (7757), 503-508, 2019 | 2503 | 2019 |
| Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate AA Chakraborty, T Laukka, M Myllykoski, AE Ringel, MA Booker, ... Science 363 (6432), 1217-1222, 2019 | 352 | 2019 |
| Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction JG Abelin, D Harjanto, M Malloy, P Suri, T Colson, SP Goulding, ... Immunity 51 (4), 766-779. e17, 2019 | 203 | 2019 |
| High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program DP Labbé, G Zadra, M Yang, JM Reyes, CY Lin, S Cacciatore, EM Ebot, ... Nature communications 10 (1), 1-14, 2019 | 148 | 2019 |
| Reduced-representation phosphosignatures measured by quantitative targeted MS capture cellular states and enable large-scale comparison of drug-induced phenotypes JG Abelin, J Patel, X Lu, CM Feeney, L Fagbami, AL Creech, R Hu, D Lam, ... Molecular & Cellular Proteomics 15 (5), 1622-1641, 2016 | 100 | 2016 |
| A library of phosphoproteomic and chromatin signatures for characterizing cellular responses to drug perturbations L Litichevskiy, R Peckner, JG Abelin, JK Asiedu, AL Creech, JF Davis, ... Cell systems 6 (4), 424-443. e7, 2018 | 78 | 2018 |
| The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction AL Creech, YS Ting, SP Goulding, JFK Sauld, D Barthelme, MS Rooney, ... Proteomics 18 (12), 1700259, 2018 | 62 | 2018 |
| Building the Connectivity Map of epigenetics: chromatin profiling by quantitative targeted mass spectrometry AL Creech, JE Taylor, VK Maier, X Wu, CM Feeney, ND Udeshi, ... Methods 72, 57-64, 2015 | 57 | 2015 |
| Functional proteomic analysis of repressive histone methyltransferase complexes reveals ZNF518B as a G9A regulator VK Maier, CM Feeney, JE Taylor, AL Creech, JW Qiao, A Szanto, PP Das, ... Molecular & Cellular Proteomics 14 (6), 1435-1446, 2015 | 51 | 2015 |
| Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma P Bandopadhayay, F Piccioni, R O’Rourke, P Ho, EM Gonzalez, ... Nature communications 10 (1), 1-16, 2019 | 48 | 2019 |
| HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase AA Chakraborty, E Nakamura, J Qi, A Creech, JD Jaffe, J Paulk, JS Novak, ... Science translational medicine 9 (398), eaal5272, 2017 | 37 | 2017 |
| A phosphoproteomic signature in endothelial cells predicts vascular toxicity of tyrosine kinase inhibitors used in CML S Gopal, Q Lu, JJ Man, W Baur, SP Rao, L Litichevskiy, M Papanastasiou, ... Blood advances 2 (14), 1680, 2018 | 13 | 2018 |
| How Y-Family DNA polymerase IV is more accurate than Dpo4 at dCTP insertion opposite an N2-dG adduct of benzo [a] pyrene G Sholder, A Creech, EL Loechler DNA repair 35, 144-153, 2015 | 11 | 2015 |
| Impact of tyrosine kinase inhibitors used in chronic myeloid leukemia on signaling and epigenetics in endothelial cells S Gopal, Q Lu, W Baur, S Rao, L Litichevskiy, M Papanastasiou, A Creech, ... Blood 130 (Supplement 1), 2296-2296, 2017 | 1 | 2017 |
| The impact of chemotherapeutic agents on signaling and epigenetics in vascular endothelial cells S Gopal, A Creech, A Officer, S Egri, D Davison, JD Jaffe, IZ Jaffe Blood, The Journal of the American Society of Hematology 128 (22), 1353-1353, 2016 | 1 | 2016 |
| High fat diet accelerates MYC-driven prostate cancer through metabolic and epigenomic rewiring DP Labbe, G Zadra, M Yang, CY Lin, JM Reyes, S Cacciatore, EM Ebot, ... Cancer Research 76 (14 Supplement), 2674-2674, 2016 | 1 | 2016 |
| Enhanced HLA-II epitope prediction for immunotherapy with novel proteomics and genomics approaches. D Harjanto, JG Abelin, M Malloy, P Suri, T Colson, SP Goulding, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 97-97, 2020 | | 2020 |
| Abstract B23: Enhanced HLA-II epitope prediction for immunotherapy with novel proteomics and genomics approaches D Harjanto, JG Abelin, M Malloy, P Suri, T Colson, SP Goulding, ... Cancer Immunology Research 8 (3 Supplement), B23-B23, 2020 | | 2020 |
| A novel HLA-peptide profiling workflow called MAPTACTM (Mono-Allelic-Purification-with-Tagged-Allele-Constructs) leverages mass spectrometry to improve neoantigen prediction LR Serrano, D Barthelme, RC Oslund, AL Creech, T Colson, SP Goulding, ... MOLECULAR & CELLULAR PROTEOMICS 18 (8), S62-S62, 2019 | | 2019 |
| The UTX Tumor Suppressor Directly Senses Oxygen to Control Chromatin and Cell Fate AA Chakraborty, T Laukka, M Myllykoski, AE Ringel, MA Booker, ... bioRxiv, 510479, 2019 | | 2019 |
